Cargando…
Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurol...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438400/ https://www.ncbi.nlm.nih.gov/pubmed/36068807 http://dx.doi.org/10.1016/j.radcr.2022.06.090 |
_version_ | 1784781821328752640 |
---|---|
author | Araújo, Victor Oliveira Marcelino, Paulo Filho Soares Rabelo, Samuel Ramos Junior, Fabio Antonio Serra de Lima Teixeira, Vitor Gil Gonçalves Eisele, Roberto Rocha Eisele, Afonso Rocha de Carvalho, João Pedro Serenario Ferreira Filho, Luciano Barroso de Albuquerque de Medeiros, Sara Diógenes Peixoto Oliveira, Leandro Freitas Claudino dos Santos, Julio Cesar Júnior, Euldes Mendes |
author_facet | Araújo, Victor Oliveira Marcelino, Paulo Filho Soares Rabelo, Samuel Ramos Junior, Fabio Antonio Serra de Lima Teixeira, Vitor Gil Gonçalves Eisele, Roberto Rocha Eisele, Afonso Rocha de Carvalho, João Pedro Serenario Ferreira Filho, Luciano Barroso de Albuquerque de Medeiros, Sara Diógenes Peixoto Oliveira, Leandro Freitas Claudino dos Santos, Julio Cesar Júnior, Euldes Mendes |
author_sort | Araújo, Victor Oliveira |
collection | PubMed |
description | The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection. |
format | Online Article Text |
id | pubmed-9438400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94384002022-09-02 Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A Araújo, Victor Oliveira Marcelino, Paulo Filho Soares Rabelo, Samuel Ramos Junior, Fabio Antonio Serra de Lima Teixeira, Vitor Gil Gonçalves Eisele, Roberto Rocha Eisele, Afonso Rocha de Carvalho, João Pedro Serenario Ferreira Filho, Luciano Barroso de Albuquerque de Medeiros, Sara Diógenes Peixoto Oliveira, Leandro Freitas Claudino dos Santos, Julio Cesar Júnior, Euldes Mendes Radiol Case Rep Case Report The Marburg variant of MS is a rare variant that leads to a severe clinical course, with a high rate of mortality or severe residual deficits and unclear pathophysiology. A 20-year-old female patient, presented at the hospital emergency with left inferior limb paresis and visual blurring. The neurologic exam showed complete and proportionate left hemiparesis with pyramidal signs and clonus, loss of proprioception and vibration in lower limbs, tactile, and painful hypoesthesia on the left side. This report describes a rare case of Marburg variant associated with COVID-19 infection. Elsevier 2022-09-02 /pmc/articles/PMC9438400/ /pubmed/36068807 http://dx.doi.org/10.1016/j.radcr.2022.06.090 Text en © 2022 Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Araújo, Victor Oliveira Marcelino, Paulo Filho Soares Rabelo, Samuel Ramos Junior, Fabio Antonio Serra de Lima Teixeira, Vitor Gil Gonçalves Eisele, Roberto Rocha Eisele, Afonso Rocha de Carvalho, João Pedro Serenario Ferreira Filho, Luciano Barroso de Albuquerque de Medeiros, Sara Diógenes Peixoto Oliveira, Leandro Freitas Claudino dos Santos, Julio Cesar Júnior, Euldes Mendes Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A |
title | Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A |
title_full | Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A |
title_fullStr | Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A |
title_full_unstemmed | Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A |
title_short | Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A |
title_sort | tumefactive demyelination after covid-19 successfully treated with betainterferon 1a |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438400/ https://www.ncbi.nlm.nih.gov/pubmed/36068807 http://dx.doi.org/10.1016/j.radcr.2022.06.090 |
work_keys_str_mv | AT araujovictoroliveira tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT marcelinopaulofilhosoares tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT rabelosamuelramos tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT juniorfabioantonioserradelima tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT teixeiravitorgilgoncalves tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT eiselerobertorocha tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT eiseleafonsorocha tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT decarvalhojoaopedroserenarioferreira tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT filholucianobarrosodealbuquerque tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT demedeirossaradiogenespeixoto tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT oliveiraleandrofreitas tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT claudinodossantosjuliocesar tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a AT junioreuldesmendes tumefactivedemyelinationaftercovid19successfullytreatedwithbetainterferon1a |